Martin Lehr Net Worth & Insider Trades

Martin Lehr - Chief Executive Officer, Context Therapeutics Inc

As of February 21, 2023

What is Martin Lehr's Net Worth?

The current estimated net worth of Context Therapeutics Inc's Chief Executive Officer, Martin Lehr, is estimated to be about $647.01K . Martin Lehr owns about 979,891 units of Context Therapeutics Inc common stock. In the last 2 years at Context Therapeutics Inc, Martin Lehr has sold an estimated value of $0 worth.

What is Martin Lehr's Past Insider Trading?

Martin Lehr's largest purchase order was 859,878 units , worth over $426.14K on October 25, 2021. In total, Martin Lehr has made about 12 transactions over 2 years of their time at Context Therapeutics Inc. Martin Lehr usually trades in February, with the busiest year in 2023. The most recent transaction was a purchase order of 5,823 units , worth over $4.9K on February 21, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Martin Lehr's' Mailing Address?

  • Mailing address is 3675 Market Street Suite 200 Philadelphia PA 19104 PA

What are Context Therapeutics Inc's Past Insider Trades?

Context Therapeutics Inc's most recent insider trade came on February 21, 2023 by Martin Lehr who bought 5,823 units worth $4.9K . In the last 2 years, insiders at Context Therapeutics Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Martin Lehr, Chief Executive Officer,  Lynn Jennifer Minaiazary, Chief Financial Officer,  and Alex C Levit, Chief Legal Officer .

Context Therapeutics Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...